Enfusion, Inc. (NYSE:ENFN) Shares Purchased by Renaissance Technologies LLC

Renaissance Technologies LLC increased its stake in shares of Enfusion, Inc. (NYSE:ENFN) by 167.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 97,100 shares of the company’s stock after acquiring an additional 60,811 shares during the quarter. Renaissance Technologies LLC owned about 0.08% of Enfusion worth $827,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. California State Teachers Retirement System raised its stake in Enfusion by 11.0% during the 1st quarter. California State Teachers Retirement System now owns 36,002 shares of the company’s stock worth $333,000 after acquiring an additional 3,556 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in Enfusion during the 1st quarter worth $44,000. American Century Companies Inc. grew its position in Enfusion by 17.1% during the 2nd quarter. American Century Companies Inc. now owns 35,897 shares of the company’s stock worth $306,000 after purchasing an additional 5,253 shares during the last quarter. Principal Financial Group Inc. grew its position in Enfusion by 15.6% during the 2nd quarter. Principal Financial Group Inc. now owns 56,524 shares of the company’s stock worth $482,000 after purchasing an additional 7,611 shares during the last quarter. Finally, RiverPark Advisors LLC purchased a new position in Enfusion during the 2nd quarter worth $68,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.

Enfusion Stock Performance

Shares of Enfusion stock opened at $8.95 on Tuesday. Enfusion, Inc. has a 1 year low of $7.52 and a 1 year high of $10.45. The company has a market capitalization of $1.15 billion, a P/E ratio of 298.17, a PEG ratio of 2.63 and a beta of 0.92. The company’s fifty day moving average is $8.52 and its two-hundred day moving average is $8.89.

Enfusion (NYSE:ENFN) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01). Enfusion had a return on equity of 6.17% and a net margin of 1.98%. The business had revenue of $49.46 million for the quarter, compared to analysts’ expectations of $50.27 million. As a group, equities analysts expect that Enfusion, Inc. will post 0.07 earnings per share for the current year.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.